News
Crossed
Your contact person

Jan Phillip Denkers
Manager PR & Communications
T +49.40.593 62 61-23
E-Mail

Filter reset

Forschung & Hochschulen 

Fighting Chronic Diseases and Cancer

For the study, which has now been published in the journal Antioxidants, the team led by experimental physicist Florian Grüner of the University of Hamburg examined Q10 molecules which they had …
New construction receives platinum sustainability certificate from the German Sustainable Building Council. (Source: © Eppendorf SE)

Biotech & Pharma

Eppendorf expands high-tech site in Jülich

The globally positioned Eppendorf Group is expanding its bioprocess site in Jülich, Germany with the construction of a new state-of-the-art multifunctional building. The topping-out ceremony in …
Preview of the new biologics manufacturing plant J.POD® Toulouse, France (EU); (Image: © Brunerie

Biotech & Pharma

Evotec initiates ground-breaking for new biologics facility

Evotec SE today officially launched the construction of its J.POD® biologics manufacturing facility at Evotec’s Campus Curie in Toulouse, France. J.POD® Toulouse, France (EU), the second facility of …
FUSE-AI starts global sales at the G20 Digital Innovation Network in Indonesia. (Image: © FUSE_AI)

Digitalisation

FUSE-AI takes off

The G20 Digital Innovation Network is a high-level forum for sharing knowledge, fostering discussion and building partnerships between global innovation players. It aims to serve as a bridge for …
Dr. Christian Regenbrecht, CEO of CELLphenomics (2nd from left) and Prof. Dr. Hartmut Juhl, CEO and founder of Indivumed (2nd from right) are pleased about the agreed partnership. ( Picture: © Indivumed)

Biotech & Pharma

Indivumed and CELLphenomics Announce Partnership

Indivumed GmbH (“Indivumed”) and CELLphenomics GmbH (“CELLphenomics”) today announced a partnership to create a unique platform for faster and more efficient discovery and validation of therapeutic …
Repurposing drugs as the new normal (Photo: © Fraunhofer ITMP

Biotech & Pharma, Research, Academia & Universities

REMEDi4ALL project launched

REMEDi4ALL is expected to make a major leap forward in drug repurposing, or finding new therapeutic option for existing drugs, in areas where there are high unmet medical needs. It will receive 23M …
The paper

Biotech & Pharma, Research, Academia & Universities

Natural substances show promise against coronavirus

Three natural compounds present in foods like green tea, olive oil and red wine are promising candidates for the development of drugs against the coronavirus. In a comprehensive screening of a large …
The official opening of the new Eppendorf site in Singapore was done by Dr. Thomas Keller, Senior Vice President Market Region Asia/Pacific/Africa at Eppendorf, Eva van Pelt, Co-Chairman of the Management Board of Eppendorf SE, and Lina Tao, Vice President Bioprocess Sales

Biotech & Pharma

Eppendorf opens new site in Singapore

The globally active Eppendorf Group continues its growth track in Asia in a targeted manner and has opened a new site in Singapore. The new subsidiary is located in the heart of Singapore’s modern …
Aurobac will work to shift the strategy related to antibiotic treatment regimens, which at the moment leans heavily on empirical approaches using broad-spectrum and unfocused medicines. (Picture: © stock.adobe.com/Christoph Burgstedt)

Biotech & Pharma

Evotec, Boehringer Ingel­heim and bioMérieux cooperate

Evotec SE, Boehringer Ingelheim, a leading research-driven biopharmaceutical company, and bioMérieux, a world leader in in vitro diagnostics, announced today that they have formed a joint venture to …
Bernard Brandewiede, CEO of Amedon (left) and Dr. Gerrit Schönicke, Managing Director of LKF, close the partnership (Photo: © LKF)

Biotech & Pharma, Digitalisation

LKF announces partnership with Amedon

Amedon is specialized in developing and delivering web-based solutions for clinical research. More than 18-year experience in eCRF, eTMF and SAE Database makes Amedon an established and first class …
Welcome to Hamburg! Second Mayor Katharina Fegebank praises Bayerische Hausbau, MATRIX and Sysmex Europe for investing in new working environments. (Image: © Bayerische Hausbau GmbH

Biotech & Pharma

Groundbreaking for New Work Campus FLOW in Hamburg

The new work campus FLOW in Hamburg is becoming a reality: The MATRIX Group and Bayerische Hausbau laid the foundation stone together with anchor tenant Sysmex Europe and the Second Mayor Katharina …
(Picture: © Cellbox Solutions)

Biotech & Pharma

Cellbox 2.0 released

Cellbox Solutions is proud to launch the Cellbox 2.0 - the next generation of transportable incubators showcasing added features, improvements, and new software options. The company increased the …